MedDataX Logo

A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis

NCT03132610 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2017-04-28

No results posted yet for this study

Summary

A multicenter,randomized,single-blind, placebo-controlled,phase 4 clinical trial to evaluate the efficacy and safety of andrographolide sulfonate in patients with acute exacerbation of chronic bronchitis

Conditions

  • Acute Exacerbation of Chronic Bronchitis

Interventions

DRUG

andrographolide sulfonate

Conventional Therapy+Xiyanping injection

DRUG

andrographolide sulfonate simulation

Conventional Therapy+Xiyanping injection simulation

Sponsors & Collaborators

  • Jiangxi Qingfeng Pharmaceutical Co. Ltd.

    lead INDUSTRY

Principal Investigators

  • Wei Zhang · The First Affiliated Hospital of Nanchang University

  • Ping Xu · The Fourth Affiliated Hospital of Nanchang University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2017-12-01
Completion
2018-06-01

Countries

  • China

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03132610 on ClinicalTrials.gov